2’-FL markets expanding: Taiwan the latest to approve use of HMO in infant and young children products
Taiwan has become the latest APAC region to approve the use of 2â-fucosyllactose (2â-FL) â a human milk oligosaccharide (HMO) â in nutrition products for infant and young children, with firms hopeful of further sector growth as more authorities permit the use of the ingredient.
Read More
0
